Literature DB >> 19230467

Interleukin 12, interleukin 18, and tumor necrosis factor alpha release by alveolar macrophages: acute and chronic hypersensitivity pneumonitis.

Qiao Ye1, Shinobu Nakamura, Rafael Sarria, Ulrich Costabel, Josune Guzman.   

Abstract

BACKGROUND: Hypersensitivity pneumonitis (HP) is characterized by a granulomatous inflammation and may show various forms of clinical presentation, such as the acute, subacute, and chronic forms. The TH1-associated cytokines interleukin (IL) 12 and IL-18 and tumor necrosis factor alpha (TNF-alpha) may be involved in the pathogenesis of both the acute and chronic forms of HP.
OBJECTIVE: To compare the release of IL-12, IL-18, and TNF-alpha from bronchoalveolar lavage (BAL) macrophages in these 2 forms of HP.
METHODS: Patients underwent BAL 0 to 6 days after the last antigen exposure. Alveolar macrophages (AMs) from BAL in 6 patients with acute HP, 16 with chronic HP, and 11 controls were cultured for 24 hours. Cytokines in the culture supernatants were measured by enzyme-linked immunosorbent assay.
RESULTS: The production of IL-12, IL-18, and TNF-alpha by AMs was increased in patients with both acute and chronic forms in either the absence or presence of lipopolysaccharide compared with controls. The levels of IL-12, IL-18, and TNF-alpha showed no difference between patients with acute and chronic HP. The spontaneous production of IL-12, IL-18, and TNF-alpha did not correlate with the CD4/CD8 ratio in BAL. The spontaneous and lipopolysaccharide-stimulated release of IL-12 showed a positive correlation with the percentage of lymphocytes (r = .470, P = .03; r = .496, P = .02; respectively) in BAL.
CONCLUSIONS: This study demonstrates that an increased release of IL-12, IL-18, and TNF-alpha by AMs is associated with both the acute and chronic forms of HP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230467     DOI: 10.1016/S1081-1206(10)60246-3

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  9 in total

Review 1.  Immune responses to airborne fungi and non-invasive airway diseases.

Authors:  Gaëlle Vacher; Hélène Niculita-Hirzel; Thierry Roger
Journal:  Semin Immunopathol       Date:  2014-12-13       Impact factor: 9.623

Review 2.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

3.  Interstitial Lung Disease in Children Older Than 2 Years.

Authors:  Timothy J Vece; Leland L Fan
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

4.  Integrin α E β 7 (CD103) expression in bronchoalveolar lymphocytes of patients with hypersensitivity pneumonitis.

Authors:  Mariana Couto; Carmo Palmares; Marília Beltrão; Sofia Neves; Patrícia Mota; António Morais; Luís Delgado
Journal:  Int Arch Occup Environ Health       Date:  2014-05-30       Impact factor: 3.015

5.  Utility of Exhaled Nitric Oxide Fraction for the Diagnosis of Hypersensitivity Pneumonitis.

Authors:  I Ojanguren; M J Cruz; A Villar; M Barrecheguren; F Morell; X Muñoz
Journal:  Lung       Date:  2015-11-13       Impact factor: 2.584

6.  Human monocyte-derived dendritic cells exposed to microorganisms involved in hypersensitivity pneumonitis induce a Th1-polarized immune response.

Authors:  Anne-Pauline Bellanger; Jean-René Pallandre; Christophe Borg; Sophie Loeffert; Houssein Gbaguidi-Haore; Laurence Millon
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

7.  Role of IL-18 in atopic asthma is determined by balance of IL-18/IL-18BP/IL-18R.

Authors:  Huiyun Zhang; Junling Wang; Ling Wang; Hua Xie; Liping Chen; Shaoheng He
Journal:  J Cell Mol Med       Date:  2017-09-18       Impact factor: 5.310

8.  Clinical Features of Hypersensitivity Pneumonitis in Children: A Single Center Study.

Authors:  Feizhou Zhang; Tongyu Yang; Zhixuan Liu; Xuan Jia; Li Yang; Lei Wu; Lanfang Tang
Journal:  Front Pediatr       Date:  2022-01-20       Impact factor: 3.418

9.  Management of hypersensivity pneumonitis.

Authors:  Ioana O Agache; Liliana Rogozea
Journal:  Clin Transl Allergy       Date:  2013-02-04       Impact factor: 5.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.